forecast
MDMA may be approved for PTSD in 4-6 years
MDMA, an empathogen or 'love drug' producing unbounded love and open-heartedness, has shown large and promising effect sizes in clinical trials for post-traumatic stress disorder sponsored by MAPS, such that approval as a medicine might be expected in four to six years.
forecastpending
Speaker
Roland GriffithsEvidence Quote
“it's been shown to be quite a effective in treatment of post-traumatic stress disorder and those are the clinical trials that are ongoing now under the sponsorship of the maps group”
Created: 6/14/2026, 2:37:24 AM
Your notes
Loading notes...